MUSCLE SPASM IMPACTS ~84% OF U.S. ADULTS

Awaken to the possibility of relief

 

Neurana to Present at Piper Sandler Conference

Neurana Pharmaceuticals is developing a novel, non-opioid, non-drowsy,

non-cognitive impairing treatment for acute and painful muscle spasms

 

 

NEURANA - 

Bringing new treatment options for muscle spasms

Neurana’s lead product, tolperisone, has a pharmacological profile that may offer unique benefits to patients suffering from muscle spasms

Put your cursor over years in the timeline to see the history of muscle spasm treatment options

 

TOLPERISONE U.S. CLINICAL STUDIES

UNDERWAY

COMPLETED

PHASE 3

PHASE 2

PHASE 1

 

TEAM

Visionary management and investors committed to reducing the pain and disability that can accompany acute muscle spasms

Sinnova.jpg
HIG_BioHealthPartners_Web.jpg
Longitude-Logo.png
NLVP_logo_header.png
 

CONTACT NEURANA

4370 La Jolla Village Drive
Suite 860
San Diego, CA 92122
United States

contact@neuranapharma.com

© 2019 Neurana Pharmaceuticals. All Rights Reserved.